Related Experiment Video
Updated: Jul 7, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Au(III) Complexes as Pyroptosis Inducers by Targeting Mitochondrial DNA for Tumor Immunity
Lin Lv1, Jing Shi1, Zhenfan Wen1
1Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
This study introduces a novel gold(III) complex that targets mitochondrial DNA (mtDNA) to trigger pyroptosis, a form of inflammatory cell death. This approach enhances anti-tumor immunity by modulating the tumor microenvironment.
Area of Science:
- Biochemistry
- Immunology
- Materials Science
Background:
- Targeting mitochondrial DNA (mtDNA) for cancer therapy is an emerging strategy.
- Inducing inflammatory cell death, like pyroptosis, can enhance anti-tumor immune responses.
Purpose of the Study:
- To develop a novel gold(III) complex for targeting mtDNA and inducing pyroptosis.
- To investigate the immunomodulatory effects of this complex in the tumor microenvironment.
Main Methods:
- Synthesis and characterization of a cationic Au(III) Schiff base complex (Au9).
- Assessment of Au9's accumulation in mitochondria and its effects on mtDNA, ROS, ERS, and TrxR activity.
- Evaluation of pyroptosis induction via the caspase-3/GSDME pathway and DAMPs release.
- Analysis of Au9's impact on immune cell populations within the tumor microenvironment.
Main Results:
- Au9 selectively accumulates in mitochondria, damages mtDNA, inhibits TrxR, increases ROS, and induces endoplasmic reticulum stress.
- Au9 effectively triggers pyroptosis and immunogenic cell death (ICD) through the caspase-3/GSDME pathway.
- Au9 promotes dendritic cell maturation and T cell activation (CD4+/CD8+) while decreasing regulatory T cells (Tregs).
Conclusions:
- Au(III) complexes can induce pyroptosis by targeting mtDNA, representing a novel therapeutic avenue.
- This Au(III) complex synergistically enhances anti-tumor immune responses by modulating the tumor immune microenvironment.
- The findings offer innovative strategies for developing metal-based immunotherapeutic agents.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Tumor Immunotherapy
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic cells are...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
